UBS Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101M | Buy |
3,070,665
+936,446
| +44% | +$30.9M | 0.02% | 766 |
|
|
2025
Q1 | $85.8M | Buy |
2,134,219
+932,220
| +78% | +$37.5M | 0.02% | 820 |
|
|
2024
Q4 | $56.5M | Buy |
1,201,999
+888,440
| +283% | +$41.8M | 0.01% | 1041 |
|
|
2024
Q3 | $16.6M | Buy |
313,559
+13,955
| +5% | +$737K | ﹤0.01% | 1393 |
|
|
2024
Q2 | $16.2M | Buy |
299,604
+860
| +0.3% | +$46.6K | ﹤0.01% | 1339 |
|
|
2024
Q1 | $20.9M | Buy |
298,744
+24,436
| +9% | +$1.71M | 0.01% | 1170 |
|
|
2023
Q4 | $22.9M | Buy |
274,308
+77,637
| +39% | +$6.48M | 0.01% | 1044 |
|
|
2023
Q3 | $5.79M | Sell |
196,671
-104,833
| -35% | -$3.09M | ﹤0.01% | 1745 |
|
|
2023
Q2 | $9.84M | Buy |
301,504
+51,174
| +20% | +$1.67M | ﹤0.01% | 1426 |
|
|
2023
Q1 | $8.81M | Sell |
250,330
-84,887
| -25% | -$2.99M | ﹤0.01% | 1432 |
|
|
2022
Q4 | $15.4M | Buy |
335,217
+124,320
| +59% | +$5.7M | 0.01% | 1147 |
|
|
2022
Q3 | $10.2M | Buy |
210,897
+46,415
| +28% | +$2.25M | ﹤0.01% | 1281 |
|
|
2022
Q2 | $6.46M | Sell |
164,482
-83,540
| -34% | -$3.28M | ﹤0.01% | 1608 |
|
|
2022
Q1 | $9.13M | Buy |
248,022
+3,649
| +1% | +$134K | ﹤0.01% | 1513 |
|
|
2021
Q4 | $11.1M | Buy |
244,373
+109,869
| +82% | +$5.01M | ﹤0.01% | 1479 |
|
|
2021
Q3 | $4.81M | Buy |
134,504
+107,854
| +405% | +$3.85M | ﹤0.01% | 2045 |
|
|
2021
Q2 | $528K | Sell |
26,650
-61,604
| -70% | -$1.22M | ﹤0.01% | 3707 |
|
|
2021
Q1 | $2.05M | Buy |
88,254
+85,091
| +2,690% | +$1.98M | ﹤0.01% | 2749 |
|
|
2020
Q4 | $66K | Buy |
3,163
+652
| +26% | +$13.6K | ﹤0.01% | 4961 |
|
|
2020
Q3 | $55K | Buy |
2,511
+159
| +7% | +$3.48K | ﹤0.01% | 4729 |
|
|
2020
Q2 | $55K | Sell |
2,352
-17,937
| -88% | -$419K | ﹤0.01% | 4938 |
|
|
2020
Q1 | $239K | Sell |
20,289
-31,797
| -61% | -$375K | ﹤0.01% | 3766 |
|
|
2019
Q4 | $552K | Sell |
52,086
-45,275
| -47% | -$480K | ﹤0.01% | 3819 |
|
|
2019
Q3 | $1.11M | Buy |
97,361
+75,833
| +352% | +$863K | ﹤0.01% | 3122 |
|
|
2019
Q2 | $242K | Buy |
21,528
+16,569
| +334% | +$186K | ﹤0.01% | 3990 |
|
|
2019
Q1 | $40K | Sell |
4,959
-76,839
| -94% | -$620K | ﹤0.01% | 4900 |
|
|
2018
Q4 | $517K | Buy |
81,798
+74,860
| +1,079% | +$473K | ﹤0.01% | 3482 |
|
|
2018
Q3 | $68K | Buy |
6,938
+5,377
| +344% | +$52.7K | ﹤0.01% | 5037 |
|
|
2018
Q2 | $13K | Sell |
1,561
-53,349
| -97% | -$444K | ﹤0.01% | 6057 |
|
|
2018
Q1 | $396K | Buy |
54,910
+38,105
| +227% | +$275K | ﹤0.01% | 3603 |
|
|
2017
Q4 | $137K | Sell |
16,805
-8,047
| -32% | -$65.6K | ﹤0.01% | 4255 |
|
|
2017
Q3 | $361K | Buy |
24,852
+20,891
| +527% | +$303K | ﹤0.01% | 3664 |
|
|
2017
Q2 | $48K | Sell |
3,961
-10,320
| -72% | -$125K | ﹤0.01% | 4756 |
|
|
2017
Q1 | $183K | Buy |
14,281
+2,060
| +17% | +$26.4K | ﹤0.01% | 3861 |
|
|
2016
Q4 | $148K | Buy |
12,221
+7,920
| +184% | +$95.9K | ﹤0.01% | 4129 |
|
|
2016
Q3 | $40K | Buy |
4,301
+1,786
| +71% | +$16.6K | ﹤0.01% | 4824 |
|
|
2016
Q2 | $24K | Hold |
2,515
| – | – | ﹤0.01% | 5272 |
|
|
2016
Q1 | $18K | Sell |
2,515
-25,975
| -91% | -$186K | ﹤0.01% | 5446 |
|
|
2015
Q4 | $298K | Buy |
28,490
+25,946
| +1,020% | +$271K | ﹤0.01% | 3501 |
|
|
2015
Q3 | $17K | Sell |
2,544
-579
| -19% | -$3.87K | ﹤0.01% | 5567 |
|
|
2015
Q2 | $21K | Buy |
3,123
+579
| +23% | +$3.89K | ﹤0.01% | 5453 |
|
|
2015
Q1 | $17K | Sell |
2,544
-3,420
| -57% | -$22.9K | ﹤0.01% | 5496 |
|
|
2014
Q4 | $48K | Buy |
+5,964
| New | +$48K | ﹤0.01% | 4746 |
|